We use cookies to ensure that our site works correctly and provides you with the best experience. If you continue using our site without changing your browser settings, we'll assume that you agree to our use of cookies. Find out more about the cookies we use and how to manage them by reading our cookies policy. Hide

Stereospecific and Catalytic Synthesis

flasks

19 Sep 2013

SCI's Young Chemists' Panel is offering a conference on 'Hot Topics in Organic Chemistry' as part of the annual review meeting series to bring those working in synthesis up-to-date with the most innovative practices in the field. Throughout the day, established, academic experts in their particular fields will share their knowledge on selected topics. The day will be split into two sessions: 'Development of novel catalytic and stereoselective processes' and 'Synthesis of Novel Heterocyclic Scaffolds'. Topics will include catalytic phosphorus(V) mediated reactions, sigmatropic rearrangements and unusual ring systems and the changing landscape of medicinal chemistry to name a few.

Keynote speaker Prof Adam Nelson of the University of Leeds will present, 'Towards the Systematic Exploration of Chemical Space,' in which he will introduce the bias of medicinal chemists towards certain scaffolds which only cover a small, uneven part of chemical space. The lecture will go onto explore ways in which new synthetic approaches can produce diverse lead-like scaffolds with unprecedented skeletal diversity.

The second Keynote lecture will be given by Prof Eric Carreira of the Swiss Federal Institute of Technology in Zurich entitled, 'Surprises and Discoveries with Small Molecules'. The invention, synthesis and application of novel spirocyclic motifs will be examined including a description of their physiochemical properties.

This innovative seminar will take place on Wednesday 11 December 2013 in the Pfizer Lecture Theatre at the University of Cambridge, UK. Conference organisers include Benjamin Buckley of Loughborough University, Richard Castledine of Fine Contract Research Ltd, Will Farnaby of Takeda Cambridge Ltd, and Liz Jones of UCB Pharma Ltd.

Stephanie B Harris

Related Links

Share this article